XAIR
Beyond Air, Inc.
1.51
USD
This page is just a preview of the data found in TrendSpider’s full version
Beyond Air, Inc. stock is down -24.5% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 7 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 12 Oct 19:14 | 17 Nov, 2023 | 2.50 | 4 |
Beyond Air, Inc. develops nitric oxide generator and delivery systems. LungFit system is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors.
